RUISHUN BIO
Ruishun Bio was established in February 2012, focusing on the development of off-the-shelf universal DNT immune cells. A complete cell production, preparation, and quality control system has been established, and the pipeline for relapsed and refractory acute myeloid leukemia has entered clinical phase I, making it the world's first non-gene editing general-purpose tumor immune cell product . The company will further expand the indication scope of DNT cells on the basis of continuous optimization of the existing process, so as to solve the unmet clinical needs with better efficacy.
RUISHUN BIO
Industry:
Biopharma Biotechnology Life Science
Founded:
2012-02-01
Status:
Active
Total Funding:
8.7 M USD
Investors List
Baidu Ventures
Baidu Ventures investment in Series A - Ruishun Bio
Huaxia Heng Tian
Huaxia Heng Tian investment in Venture Round - Ruishun Bio
More informations about "Ruishun Bio"
Ruishun Biotechnology - VentureRadar
" Established in February 2012, Ruishun Bio is a Sino-foreign joint venture biopharmaceutical company focusing on the development of a series of global innovative immune cell drugs for …See details»
Guangdong Ruishun Biotechnology Co., Ltd. - Drug pipelines
Explore Guangdong Ruishun Biotechnology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 11 clinical trials, and 4 literature, Disease Domain:Neoplasms, Hemic and …See details»
Ruishun Bio - Drug pipelines, Patents, Clinical trials - Synapse
Last update 08 May 2025. Ruishun Bio. Private Company | 2012 | Guangdong Sheng, ChinaSee details»
广东瑞顺生物技术有限公司
广东瑞顺生物技术有限公司以“关爱生命,造福人类“和“研发老百姓用得起的创新细胞药”为己任,专注研发以dnt细胞为核心技术平台的系列现货通用型免疫细胞产品,努力成为全球现货通用型免疫 …See details»
Ruishun Bio - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 17, 2022: Series A - …See details»
Ruishun Bio - Company Profile - Tracxn
Ruishun Bio - Developer of cell therapies for cancer treatment. Raised a total funding of $8.69M over 1 round from 2 investors. Ruishun Bio has 2827 competitors.See details»
Zhejiang Ruishun Biological Technology Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Zhejiang Ruishun Biological Technology Co., Ltd. of Hangzhou, Zhejiang. Get the latest business …See details»
Ruishun Bio - Crunchbase
Companies like Ruishun Bio include Halo Labs, Nodexus, and Kinarus Therapeutics. Halo Labs Philadelphia , Pennsylvania , United States 22 Contacts 11-50 employeesSee details»
Ruishun Bio - Raised $8.69M Funding from 2 investors - Tracxn
Ruishun Bio has raised a total funding of $8.69M over 1 round from 2 investors. Investors include Baidu Ventures and Yuecai Pharmaceutical Fund. Their latest funding round was of $8.69M …See details»
RS-001 (Ruishun Biotech) - Drug Targets, Indications, Patents
May 8, 2025 RS-001(Ruishun Biotech), Initially developed by Guangdong Ruishun Biotechnology Co., Ltd., Now, its global highest R&D status is Phase 1, Therapeutic Areas: …See details»
Series A - Ruishun Bio - 2022-08-17 - Crunchbase
Aug 17, 2022 Ruishun Bio raised $8700782 on 2022-08-17 in Series A. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log …See details»
Ruishun Biotechnology | VentureRadar
Established in February 2012, Ruishun Bio is a Sino-foreign joint venture biopharmaceutical company focusing on the development of a series of global innovative immune cell drugs for …See details»
Lighthouse8 - VentureRadar
Ruishun Biotechnology Unknown Privately Held Established in February 2012, Ruishun Bio is a Sino-foreign joint venture biopharmaceutical company focusing on the development of a series …See details»
Guangdong Ruishun Biotechnology Co., Ltd. (广东瑞顺生物技术有 …
了解Guangdong Ruishun Biotechnology Co., Ltd. (广东瑞顺生物技术有限公司)公司的药物管线，治疗领域，技术平台，以及它的11项临床试验, 48篇新闻和4篇文献，疾病领域:肿瘤，血液 …See details»
Peptide Biotechnology - Crunchbase
Peptide Biotech, Zor Pharmaceuticals, Ruishun Bio, Molecular Medicine, Amino Medical Science, and Cisterna Biologics are all involved in the biopharmaceutical industry. Zor Pharmaceuticals, …See details»
Ruishun Bio - Updates, News, Events, Signals & Triggers
Ruishun Bio is a complete cell production, preparation, and quality control system.See details»
Venture Round - Ruishun Bio - 2022-03-16 - Crunchbase
Ruishun Bio raised an undisclosed amount on 2022-03-16 in Venture Round. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
Ruishun Bio | Competitors - Tracxn
Details about top competitor companies of Ruishun Bio. Details about top competitor companies of Ruishun Bio Toggle navigation. Solutions. By Investment Industry. Venture Capital Funds …See details»
瑞顺生物完成5900万元人民币A+轮融资，加速推进现货通用 …
Aug 19, 2022 近日，现货通用型dnt细胞药物开发全球领跑者——广东瑞顺生物技术有限公司（简称“瑞顺生物”或“公司”）宣布完成5900万 ...See details»
Welcome to BIO 2025: Collaboration can't wait. | BIO
2 days ago As we kick off BIO 2025, the world’s largest biotech gathering, BIO emphasizes that collaboration can’t wait. Today’s theme: Collaboration—between government and industry, …See details»